Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer

Anticancer Research

Volumn 19, Issue 5 C, 1999, Pages 4515-4521

  Wada, Noriaki ^a   Ishii, Seiichiro ^b   Ikeda, Tadashi ^a   Enomoto, Kohji ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Bone metastasis; Breast cancer; Spectrophotometric assay; Tartrate resistant acid phosphatase

Indexed keywords

ACID PHOSPHATASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSTEOCLAST; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ACID PHOSPHATASE; ADENOCARCINOMA; ADULT; AGED; ALKALINE PHOSPHATASE; AMINO ACIDS; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOENZYMES; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033427953     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Coleman RE and Rubens RD: The clinical course of bone metastases from breast cancer. Br J Cancer 55: 61-66, 1987.
2. Nielsen OS, Munro AJ and Tannock IF: Bone metastases: pathophysiology and management policy. J Clin Oncol 19: 509-524, 1991.
3. Moro L, Gazzarrini C, Modricky C, et al: High predictivity of galactosyl- hydroxylysine in urine as an indicator of bone metastases from breast cancer. Clin Chem 36: 772-774, 1990.
4. Sano M, Kushida K, Takahashi M, et al: Urinary pyrid inoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis. Br J Cancer 70: 701-703, 1994.
5. Yam LT: Clincal significance of the human acid phosphatases. A review. Am J Med 56: 604-616, 1974.
6. Tavassoli M, Rizo M and Yam L Elevation of serum acid phosphatase in cancers with bone metastasis. Cancer 45: 2400-2403, 1980.
7. Desoize B, Delvincourt C and Comoe L: Comparision of 4 techniques of Alkaline phosphatase isoemzyme assay. Clin Chem Enzymol Commun 2: 107-114, 1990.
8. Minkin C: Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34: 285-290, 1982.
9. Stepan JJ, Zichova M, Lachmanova J and Pacovsky V: Plasma tartrate resistant acid phosphatase: a marker for osteoclastic bone resorption. Acta Univ Carol Med Praha 32: 345-53, 1986.
10. Lam KW, Dannaher C, Letchford S, Eastlund T, Li CY and Yam LT: Tartrate- resistant acid phosphatase in serum of cancer patients. Clin Chem 30: 457-459, 1984.
11. Cheung CK, Panesar NS, Haines C, Masarei J and Swaminathan R: Immunoassay of a tartrate-resistant acid phosphatase in serum [see comments]. Clin Chem 41: 679-686, 1995.
12. Kraenzlin M: Development of immuniassay for human serum osteoclastic tartrate-resistant acid phosphatase. J Clin Endocrinol Metab 71: 442-451, 1990.
13. Osawa S, Iida S, Yonemitsu H, Kuroiwa K, Katayama K and Nagasawa T: Prostatic acid phosphatase assay with self-indicating substrate 2,6-dichloro-4-acetylphenyl phosphate. Clin Chem 41: 200-203, 1995.
14. Yoshimura Y, Ohnishi, K., Hamamura M, Oda T and Sohda T: Automated high-performance liquid chromatograhic determination hydroxylysylpyridinoline and lysylpyridinoline in urine using a column-switching method. J Chromatogr 613: 43-49, 1993.
15. th edition. Tokyo, Kaneharashuppan, 1996.
16. Eggert FM: Stable acid phosphatase: II. Effects of pH and inhibitors. Histochemistry 66: 319-329, 1980.
17. Chambers TJ, Fuller Kand Darby JA: Hormonal regulation of acid phosphatase release by osteoclasts disaggregated from neonatal rat bone. J Cell Physioll 32: 90-96, 1987.
18. Chen J, Yam LT, Janckila AJ, Li CY and Lam WK: Significance of "high" acid phosphatase activity in the serum of normal children. Clin Chem 25: 719-722, 1979.
19. de la Piedra C, Torres R, Rapado A, Diaz Curiel M and Castro N: Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis. Calcif Tissue Int 45: 58-60, 1989.
20. Lau KH, Onishi T, Wergedal JE, Singer FR and Baylink DJ: Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin Chem 33: 458-62, 1987.
21. Stepan JJ, Silinkova Malkova E, Havranek T, et al: Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism. Clin Chim Actal 33: 189-200, 1983.
22. Bais R and Edwards JB: An optimized continuous-monitoring procedure for semiautomated determination of serum acid phosphatase activity. Clin Chem 22: 2025-2028,1976.
23. Cooper JD, Turnell DC and Price CP: The estimation of serum acid phosphatase using alpha-naphthyl phosphate as substrate: observations on the use of Fast Red TR salt in the assay. Clin Chim Actal 26: 297-306, 1982.
24. Kind PRN and King EJ: Estimation of plasma phsphatase by determination of hydrolyzed phenol with aminoantipyrine. J Clin Pathol 7: 322-326, 1954.
25. Morin LG: Ammonium thymolphthalein monophosphate as a new substrate for alkaline and acid phosphatase determinations in serum. Clin Chem 19: 1135-1138, 1973.
26. Roy AV, Brower ME and Hayden JE: Sodium thymolphthalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum. Clin Chem 17: 1093-102, 1971.
27. Scarnecchia L, Minisola S, Pacitti MT, et al: Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover. Scand J Clin Lab Invest 51: 517-524, 1991.
28. Stepan JJ, Tesarova A, Havranek T, Jodl J, Formankova J and Pacovsky V: Age and sex dependency of the biochemical indices of bone remodelling. Clin Chim Acta 151: 273-283, 1985.
29. Desoize B, Veiler V, Pourny C, Comoe L and Jardillier JC: Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients. Antican cer Res 9: 1105-1109, 1989.
30. Nguyen M, Bonneterre J, Hecquet B, Desoize B and Demaille A: Plasma acid and alkaline phosphatase in patients with breast cancer. Anticancer Res 11: 831-833, 1991.
31. Perez DJ, Powles TJ, Milan J, et al: Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy. Lancet 2: 613-616, 1983.
32. Rico H and Villa LF: Serum tartrate-resistant acid phosphatase (TRAP) as a biochemical marker of bone remodeling. Calcif Tissue Int 52: 149-150, 1993.